MicroRNAs diagnostic and prognostic value as predictive markers for malignant mesothelioma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNAs diagnostic and prognostic value as predictive markers for malignant mesothelioma
Authors
Keywords
-
Journal
Archives of Environmental & Occupational Health
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2020-04-20
DOI
10.1080/19338244.2020.1747966
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-wide profiling reveals novel microRNAs in hand-spinning-specific chrysotile exposure
- (2019) Junlin Jia et al. Epigenomics
- Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma
- (2019) Carmina Jiménez-Ramírez et al. LUNG
- Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients
- (2018) Marwa Matboli et al. Biomarkers in Medicine
- Hétérogénéité moléculaire des mésothéliomes pleuraux malins
- (2018) Robin Tranchant et al. BULLETIN DU CANCER
- Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma
- (2018) Thomas G. Johnson et al. Journal of Thoracic Oncology
- Serum mesothelin and other biomarkers: what have we learned in the last decade?
- (2018) Alfonso Cristaudo et al. Journal of Thoracic Disease
- Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review
- (2018) Rossella Bruno et al. Journal of Thoracic Disease
- Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
- (2018) Caterina Ledda et al. Cancers
- Four-miRNA signature to identify asbestos-related lung malignancies
- (2018) Lory Santarelli et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma
- (2018) Tian He et al. Molecular Oncology
- Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers
- (2018) Georg Johnen et al. Scientific Reports
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Characterization of single circulating tumor cells
- (2017) Catherine Alix-Panabières et al. FEBS LETTERS
- miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma
- (2017) Fabian Dominik Mairinger et al. VIRCHOWS ARCHIV
- Progress of research on microRNAs with diagnostic value in asbestos exposure: A call for method standardization
- (2017) Luigina Micolucci et al. BioScience Trends
- Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
- (2017) Sabrina Lagniau et al. Oncotarget
- Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
- (2017) Anna Truini et al. Oncotarget
- Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
- (2017) Kentaro Inamura Cancers
- Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease
- (2017) Tommaso Cavalleri et al. PLoS One
- Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
- (2017) Chiara De Santi et al. Scientific Reports
- KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma
- (2016) Yuen Yee Cheng et al. Molecular Cancer
- Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers
- (2016) Ilaria Bononi et al. Oncotarget
- Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis
- (2016) Luigina Micolucci et al. Oncotarget
- A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma
- (2015) Steven C. Kao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- MicroRNA (miRNA) in cancer
- (2015) Kaladhar B Reddy Cancer Cell International
- Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma
- (2015) K. A. Birnie et al. MOLECULAR CANCER RESEARCH
- miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma
- (2015) Marissa Williams et al. Oncotarget
- Challenges in Using Circulating miRNAs as Cancer Biomarkers
- (2015) Paola Tiberio et al. Biomed Research International
- MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma
- (2014) Michaela B. Kirschner et al. Molecular Oncology
- Increased Levels of C-C Chemokine RANTES in Asbestos Exposed Workers and in Malignant Mesothelioma Patients from an Hyperendemic Area
- (2014) Manola Comar et al. PLoS One
- Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
- (2014) Daniel G. Weber et al. PLoS One
- Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
- (2013) G. Reid et al. ANNALS OF ONCOLOGY
- Biomarker research with prospective study designs for the early detection of cancer
- (2013) B. Pesch et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Molecular pathogenesis of malignant mesothelioma
- (2013) Y. Sekido CARCINOGENESIS
- The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma
- (2013) Takayuki Muraoka et al. LUNG CANCER
- Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
- (2012) Michaela B. Kirschner et al. Journal of Thoracic Oncology
- Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma – A Pilot Study
- (2012) Daniel G. Weber et al. PLoS One
- Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer
- (2011) Penny Nymark et al. GENES CHROMOSOMES & CANCER
- Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
- (2011) Lory Santarelli et al. PLoS One
- From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay
- (2011) Stephan Kraemer et al. PLoS One
- hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma
- (2010) H. I. Pass et al. CANCER RESEARCH
- Circulating microRNAs: Association with disease and potential use as biomarkers
- (2010) Glen Reid et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
- (2010) Gretchen V. Gee et al. INTERNATIONAL JOURNAL OF CANCER
- Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma
- (2010) Sergey V. Ivanov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications
- (2009) Sara Busacca et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma
- (2009) Y. Goto et al. CANCER RESEARCH
- CDKN2A,NF2, andJUNare dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis
- (2009) Mohamed Guled et al. GENES CHROMOSOMES & CANCER
- Profiling Tumor-Associated Markers for Early Detection of Malignant Mesothelioma: An Epidemiologic Study
- (2008) M. Amati et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome
- (2008) B. C. Christensen et al. CANCER RESEARCH
- Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
- (2008) B. C. Christensen et al. CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now